| Literature DB >> 36246391 |
Marleny M Vega1, Geng Li1, Mohammad S Shourijeh1, Di Ao1, Robert C Weinschenk2, Carolynn Patten3,4,5, Josep M Font-Llagunes6,7, Valerae O Lewis8, Benjamin J Fregly1.
Abstract
An emerging option for internal hemipelvectomy surgery is custom prosthesis reconstruction. This option typically recapitulates the resected pelvic bony anatomy with the goal of maximizing post-surgery walking function while minimizing recovery time. However, the current custom prosthesis design process does not account for the patient's post-surgery prosthesis and bone loading patterns, nor can it predict how different surgical or rehabilitation decisions (e.g., retention or removal of the psoas muscle, strengthening the psoas) will affect prosthesis durability and post-surgery walking function. These factors may contribute to the high observed failure rate for custom pelvic prostheses, discouraging orthopedic oncologists from pursuing this valuable treatment option. One possibility for addressing this problem is to simulate the complex interaction between surgical and rehabilitation decisions, post-surgery walking function, and custom pelvic prosthesis design using patient-specific neuromusculoskeletal models. As a first step toward developing this capability, this study used a personalized neuromusculoskeletal model and direct collocation optimal control to predict the impact of ipsilateral psoas muscle strength on walking function following internal hemipelvectomy with custom prosthesis reconstruction. The influence of the psoas muscle was targeted since retention of this important muscle can be surgically demanding for certain tumors, requiring additional time in the operating room. The post-surgery walking predictions emulated the most common surgical scenario encountered at MD Anderson Cancer Center in Houston. Simulated post-surgery psoas strengths included 0% (removed), 50% (weakened), 100% (maintained), and 150% (strengthened) of the pre-surgery value. However, only the 100% and 150% cases successfully converged to a complete gait cycle. When post-surgery psoas strength was maintained, clinical gait features were predicted, including increased stance width, decreased stride length, and increased lumbar bending towards the operated side. Furthermore, when post-surgery psoas strength was increased, stance width and stride length returned to pre-surgery values. These results suggest that retention and strengthening of the psoas muscle on the operated side may be important for maximizing post-surgery walking function. If future studies can validate this computational approach using post-surgery experimental walking data, the approach may eventually influence surgical, rehabilitation, and custom prosthesis design decisions to meet the unique clinical needs of pelvic sarcoma patients.Entities:
Keywords: computational modeling; internal hemipelvectomy surgery; neuromusculoskeletal modeling; optimal control; orthopedic biomechanics; pelvic sarcoma; predictive simulation; treatment optimization
Year: 2022 PMID: 36246391 PMCID: PMC9559731 DOI: 10.3389/fbioe.2022.855870
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
FIGURE 1(A) Sample x-ray image of a pelvic cancer patient who received internal hemipelvectomy surgery with no reconstruction. (B) Sample x-ray image of a pelvic cancer patient who received internal hemipelvectomy surgery with allograph reconstruction and a total hip replacement. Images courtesy of Dr. Valerae Lewis, MD Anderson Cancer Center patient education DVD.
Right leg muscles from which surface or fine-wire (*) EMG data were collected.
|
|
| Adductor magnus |
| Gluteus maximus lateralis |
| Gluteus maximus medius |
| Gluteus medius |
|
|
| Semimembranosus |
| Semitendinosus |
| Biceps femoris long head |
| Rectus femoris |
| Tensor fascia latae |
| Gracilis |
|
|
| Vastus lateralis |
| Vastus medialis |
|
|
| Gastrocnemius medialis |
| Gastrocnemius lateralis |
| Tibialis anterior |
|
|
|
|
|
|
| Peroneus longus |
| Soleus |
|
|
|
|
FIGURE 2Overview of the computational processes used for model personalization and treatment optimization. Top row: Model personalization process. Bottom row: Treatment optimization process.
Overview of direct collocation optimal control problem formulations used for model personalization and treatment optimization.
| Model personalization | ||||
|---|---|---|---|---|
| Cost Function | Constraints | Static Parameters | Controls | |
| Foot-ground contact model calibration | Track experimental foot marker positions, full-body joint angles, ground reactions, and lower body and back joint moments; Minimize joint jerk | Satisfy skeletal dynamics; Enforce joint angle periodicity | Foot-ground contact model parameters | Joint jerk |
| Neural control model calibration | Track experimental full-body joint angles, ground reactions, lower body and back joint moments, and muscle activations; Minimize joint jerk | Satisfy skeletal dynamics; Match inverse dynamic lower body and back joint moments using synergy controls; Enforce unit magnitude synergy vectors; Enforce ground reaction and joint angle periodicity | Synergy vector weights | Synergy activations; Joint jerk |
| Neuromusculoskeletal model verification | Minimize joint jerk | Satisfy skeletal dynamics; Match inverse dynamic lower body joint and lumbar joint moments using synergy controls; Enforce ground reaction and joint angle periodicity | None | Synergy activations; Joint jerk |
| Strengthening or weakening the psoas muscle | Track synergy activations, track upper body joint angles, minimize joint jerk | Satisfy skeletal dynamics; Match inverse dynamic lower body and back joint moments using synergy controls; Enforce ground reaction and joint angle periodicity; Enforce bounds on muscle activations | None | Synergy activations; Joint jerk |
Muscles included in the enhanced base OpenSim musculoskeletal model. Muscles listed in bold text were removed from the operated side of the model when generating post-surgery walking predictions.
| Adductor brevis | Gracilis |
| Adductor Longus |
|
| Adductor Magnus | Pectineus |
| Adductor Magnus (distal) | Peroneus Brevis |
| Adductor Magnus (ischial) | Peroneus Longus |
| Adductor Magnus (middle) | Piriformis |
| Adductor Magnus (proximal) | Psoas |
| Biceps Femoris Long Head |
|
| Biceps Femoris Short Head |
|
| Extensor Digitorium Longus |
|
| Extensor Hallucis Longus | Semimembranosus |
| Flexor Digitorium Longus | Semitendinosus |
| Flexor Hallucis Longus | Soleus |
| Gastrocnemius Lateral Head |
|
| Gastrocnemius Medial Head | Tibialis Anterior |
|
| Tibialis Posterior |
| Gluteus Maximus | Vastus Lateralis |
| Gluteus Maximus (inferior) | Vastus Medialis |
| | Vastus Intermedius |
| | Rectus Abdominus |
|
|
|
| |
|
| |
|
| |
|
|
|
|
| | |
| | |
| |
A few heads of these muscles remain.
Comparison of experimental pre-surgery and predicted post-surgery clinical gait measures. Psoas strength is indicated as percent of pre-surgery value
| Condition | Psoas strength | CoT | Metabolic cost (J) | Spatial symmetry | Temporal symmetry | Stance width (m) | Stride length (m) | Stride time (s) |
|---|---|---|---|---|---|---|---|---|
| Pre-Surgery | 100% | 5.98 | 620 | 0.49 | 0.50 | 0.082 | 1.55 | 1.06 |
| Post-Surgery | 150% | 5.52 | 571 | 0.51 | 0.47 | 0.071 | 1.55 | 1.10 |
| 100% | 5.75 | 548 | 0.42 | 0.47 | 0.23 | 1.43 | 1.05 |
FIGURE 3Animation strip comparing the subject’s experimental walking motion (translucent skeleton) to his predicted walking motion when post-surgery operated side psoas strength was 100% of its pre-surgery value (opaque skeleton).
FIGURE 4Animation strip comparing the subject’s experimental walking motion (translucent skeleton) to his predicted walking motion when post-surgery operated side psoas strength was 150% of its pre-surgery value (opaque skeleton).
Root-mean-square (RMS) differences between pre-surgery and predicted post-surgery joint angles. Percentage of Fmax indicates the percent of pre-surgery psoas peak isometric strength used to generate the post-surgery walking prediction.
| RMS difference (deg) | ||
|---|---|---|
| Joint angle | 150% Fmax | 100% Fmax |
| Pelvis Tilt | 3.99 | 4.48 |
| Pelvis List | 10.44 | 13.27 |
| Pelvis Rotation | 12.56 | 12.12 |
| Operated Hip Flexion | 5.59 | 12.54 |
| Operated Hip Adduction | 16.09 | 20.72 |
| Operated Hip Rotation | 17.03 | 14.36 |
| Operated Knee Flexion | 9.04 | 18.13 |
| Operated Ankle Dorsiflexion | 8.73 | 6.79 |
| Operated Ankle Inversion | 12.01 | 25.59 |
| Non-operated Hip Flexion | 4.71 | 4.19 |
| Non-operated Hip Adduction | 10.64 | 12.18 |
| Non-operated Hip Rotation | 6.15 | 6.03 |
| Non-operated Knee Flexion | 11.72 | 8.66 |
| Non-operated Ankle Dorsiflexion | 6.24 | 5.80 |
| Non-operated Ankle Inversion | 20.41 | 15.97 |
| Lumbar Extension | 4.78 | 4.37 |
| Lumbar Bending | 18.72 | 16.02 |
| Lumbar Rotation | 8.09 | 7.15 |
FIGURE 5Experimental pre-surgery and predicted post-surgery joint angles for post-surgery psoas strengths of 100%, and 150% of the pre-surgery value. The gait cycle begins with operated leg heel strike.
Root-mean-square (RMS) differences between pre-surgery and predicted post-surgery joint moments. Percentage of Fmax indicates the percent of pre-surgery psoas peak isometric strength used to generate the post-surgery walking prediction.
| RMS difference (Nm) | |||
|---|---|---|---|
| Joint moment | 150% Fmax | 100% Fmax | |
| Operated Hip Flexion | 18.07 | 19.07 | |
| Operated Hip Adduction | 19.43 | 21.70 | |
| Operated Hip Rotation | 51.66 | 54.54 | |
| Operated Knee Flexion | 24.91 | 24.29 | |
| Operated Ankle Dorsiflexion | 10.56 | 11.09 | |
| Operated Ankle Inversion | 9.13 | 7.91 | |
| Non-operated Hip Flexion | 23.30 | 24.05 | |
| Non-operated Hip Adduction | 19.59 | 21.81 | |
| Non-operated Hip Rotation | 20.20 | 16.79 | |
| Non-operated Knee Flexion | 28.51 | 22.61 | |
| Non-operated Ankle Dorsiflexion | 4.78 | 11.16 | |
| Non-operated Ankle Inversion | 9.53 | 7.49 | |
| Lumbar Extension | 8.76 | 8.49 | |
| Lumbar Bending | 39.04 | 39.01 | |
| Lumbar Rotation | 10.95 | 7.89 | |
FIGURE 6Experimental pre-surgery and predicted post-surgery joint moments for post-surgery psoas strengths of 100%, and 150% of the pre-surgery value. The gait cycle begins with operated leg heel strike.
Root-mean-square (RMS) differences between pre-surgery and predicted post-surgery synergy activations. Percentage of Fmax indicates the percent of pre-surgery psoas peak isometric strength used to generate the post-surgery walking prediction.
| RMS difference (unitless) | |||
|---|---|---|---|
| Side | Synergy no. | 150% Fmax | 100% Fmax |
| Non-operated | 1 | 0.057 | 0.062 |
| 2 | 0.065 | 0.057 | |
| 3 | 0.056 | 0.067 | |
| 4 | 0.063 | 0.051 | |
| 5 | 0.057 | 0.061 | |
| 6 | 0.067 | 0.068 | |
| Operated | 1 | 0.048 | 0.054 |
| 2 | 0.067 | 0.068 | |
| 3 | 0.060 | 0.064 | |
| 4 | 0.068 | 0.068 | |
| 5 | 0.067 | 0.066 | |
| 6 | 0.065 | 0.048 | |